Karin A Koinig1, Christoph Arnold2, Jens Lehmann3,4, Johannes Giesinger3, Stefan Köck1, Wolfgang Willenbacher1,4, Roman Weger1,4, Bernhard Holzner3, Ute Ganswindt2, Dominik Wolf1, Reinhard Stauder1. 1. Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria. 2. Department of Radiation Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria. 3. University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria. 4. OncoTyrol-Center for Personalized Cancer Medicine, Innsbruck, Austria.
Abstract
BACKGROUND: To permit timely mitigation of adverse effects on overall clinical outcome, it is essential to understand how the pandemic influences distress and health-related quality of life (HRQOL) in cancer patients during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: In this cross-sectional study, adult cancer patients, without COVID-19 symptoms, completed a 13-item questionnaire about the pandemic's impacts on distress and everyday-life; associations with age, sex, or impaired HRQOL were then assessed by binary logistic regressions. In a subsample of patients with HRQOL assessment available from both before and during the pandemic, we evaluated the pandemic's impact on longitudinal changes in HRQOL reported within 6 months before versus during the COVID-19 lockdown using McNemar's test, and thresholds for clinical importance. RESULTS: We consecutively enrolled 240 patients with solid (50%) or hematological (50%) cancers. Median age was 67 years, 46% were females. The majority ranked heeding their health (80%) and keeping their appointment schedule in hospital (78%) as important. Being younger than 60, or aged 60-70 was independently associated with limitations in everyday life (OR = 3.57, p < 0.001; and 2.05, p = 0.038); female individuals and those with restricted emotional functioning were more distressed by the COVID-19 situation (OR = 2.47, p = 0.040; and 3.17, p = 0.019); the latter group was also significantly more concerned about being a patient at risk (OR = 2.21, p = 0.029). Interestingly, in a subsample of patients (n = 47), longitudinal comparisons pre- versus during the pandemic revealed that HRQOL was not substantially affected by the pandemic. CONCLUSION: Particularly younger and female cancer patients, and those with impaired emotional functioning are distressed by COVID-19. During the first COVID-19 lockdown, cancer patients remained predominantly resilient. This analysis highlights the need to mitigate distress situations in vulnerable patients and thereby enhance resilience during pandemics.
BACKGROUND: To permit timely mitigation of adverse effects on overall clinical outcome, it is essential to understand how the pandemic influences distress and health-related quality of life (HRQOL) in cancerpatients during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: In this cross-sectional study, adult cancerpatients, without COVID-19 symptoms, completed a 13-item questionnaire about the pandemic's impacts on distress and everyday-life; associations with age, sex, or impaired HRQOL were then assessed by binary logistic regressions. In a subsample of patients with HRQOL assessment available from both before and during the pandemic, we evaluated the pandemic's impact on longitudinal changes in HRQOL reported within 6 months before versus during the COVID-19 lockdown using McNemar's test, and thresholds for clinical importance. RESULTS: We consecutively enrolled 240 patients with solid (50%) or hematological (50%) cancers. Median age was 67 years, 46% were females. The majority ranked heeding their health (80%) and keeping their appointment schedule in hospital (78%) as important. Being younger than 60, or aged 60-70 was independently associated with limitations in everyday life (OR = 3.57, p < 0.001; and 2.05, p = 0.038); female individuals and those with restricted emotional functioning were more distressed by the COVID-19 situation (OR = 2.47, p = 0.040; and 3.17, p = 0.019); the latter group was also significantly more concerned about being a patient at risk (OR = 2.21, p = 0.029). Interestingly, in a subsample of patients (n = 47), longitudinal comparisons pre- versus during the pandemic revealed that HRQOL was not substantially affected by the pandemic. CONCLUSION: Particularly younger and female cancerpatients, and those with impaired emotional functioning are distressed by COVID-19. During the first COVID-19 lockdown, cancerpatients remained predominantly resilient. This analysis highlights the need to mitigate distress situations in vulnerable patients and thereby enhance resilience during pandemics.
Authors: Jörg Haier; Johannes Beller; Kristina Adorjan; Stefan Bleich; Moritz De Greck; Frank Griesinger; Alexander Hein; René Hurlemann; Sören Torge Mees; Alexandra Philipsen; Gernot Rohde; Georgia Schilling; Karolin Trautmann; Stephanie E Combs; Siegfried Geyer; Jürgen Schäfers Journal: Healthcare (Basel) Date: 2022-05-31
Authors: Sara Izadi-Najafabadi; Lisa McQuarrie; Stuart Peacock; Ross Halperin; Leah Lambert; Craig Mitton; Helen McTaggart-Cowan Journal: Curr Oncol Date: 2022-06-10 Impact factor: 3.109
Authors: Hannah Glick; Aashima Sarin; Lindsey A Herrel; Lindsay Ma; Marissa Moore; Inga Van Wieren; Stephanie Chisolm; Diana O'Dell; Ashley Duby; Todd M Morgan; James E Montie; Daniela Wittmann Journal: Eur J Cancer Care (Engl) Date: 2022-08-09 Impact factor: 2.328